The economics of using prophylactic antibiotic-loaded bone cement in total knee replacement

Bone and Joint Journal

Volumn 96 B, Issue 1, 2014, Pages 65-69

  Gutowski, C J ^a   Zmistowski, B M ^a   Clyde, C T ^a   Parvizi, J ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC BONE CEMENT; POLY(METHYL METHACRYLATE); TOBRAMYCIN; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERIPROSTHETIC JOINT INFECTION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; VERY ELDERLY; YOUNG ADULT;

EID: 84892592206     PISSN: None     EISSN: 20494408     Source Type: Journal    
DOI: 10.1302/0301-620X.96B1.31428     Document Type: Article

References (23)

1. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg [Am] 2007;89-A:780-785.
2. Lavernia C, Lee DJ, Hernandez VH. The increasing financial burden of knee revision surgery in the United States. Clin Orthop Relat Res 2006;446:221-226.
3. Jiranek WA, Hanssen AD, Greenwald AS. Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement. J Bone Joint Surg [Am] 2006;88-A:2487-2500.
4. Oga M, Sugioka Y, Hobgood CD, Gristina AG, Myrvik QN. Surgical biomaterials and differential colonization by Staphylococcus epidermidis. Biomaterials 1988;9:285-289.
5. Hanssen AD, Spangehl MJ. Practical applications of antibiotic-loaded bone cement for treatment of infected joint replacements. Clin Orthop Relat Res 2004;427:79-85.
6. Bourne RB. Prophylactic use of antibiotic bone cement: an emerging standard: in the affirmative. J Arthroplasty 2004;19(Suppl):69-72.
7. Parvizi J, Saleh KJ, Ragland PS, Pour AE, Mont MA. Efficacy of antibioticimpregnated cement in total hip replacement. Acta Orthop 2008;79:335-341.
8. Josefsson G, Gudmundsson G, Kolmert L, Wijkström S. Prophylaxis with systemic antibiotics versus gentamicin bone cement in total hip arthroplasty: a five-year survey of 1688 hips. Clin Orthop Relat Res 1990;253:173-178.
9. Engesaeter LB, Lie SA, Espehaug B, et al. Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22, 170 primary hip replacements followed 0-14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 2003;74:644-651.
10. Hanssen AD. Prophylactic use of antibiotic bone cement: an emerging standard: in opposition. J Arthroplasty 2004;19(Suppl):73-77.
11. Randelli P, Evola FR, Cabitza P, et al. Prophylactic use of antibiotic-loaded bone cement in primary total knee replacement. Knee Surg Sports Traumatol Arthrosc 2010;18:181-186.
12. Lewis G. Effect of two variables on the fatigue performance of acrylic bone cement: mixing method and viscosity. Biomed Mater Eng 1999;9:197-207.
13. Arciola CR, Campoccia D, Montanaro L. Effects on antibiotic resistance of Staphylococcus epidermidis following adhesion to polymethylmethacrylate and to silicone surfaces. Biomaterials 2002;23:1495-1502.
14. Clyburn TA, Cui Q. Antibiotic laden cement: current state of the art. AAOS Now 2007. http://www.aaos.org/news/bulletin/may07/clinical7.asp (date last accessed 4 November 2013).
15. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-619.
16. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
17. Parvizi J, Zmistowski B, Berbari EF, et al. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res 2011;469:2992-2994.
18. Kurtz SM, Lau E, Schmier J, et al. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty 2008;23:984-991.
19. Penner MJ, Masri BA, Duncan CP. Elution characteristics of vancomycin and tobramycin combined in acrylic bone-cement. J Arthroplasty 1996;11:939-944.
20. Chiu FY, Chen CM, Lin J, Lo WH. Cefuroxime-impregnated cement in primary total knee arthroplasty: a prospective, randomized study of three hundred and forty knees. J Bone Joint Surg [Am] 2002;84-A:759-762.
21. Parvizi J, Pawasarat IM, Azzam KA, et al. Periprosthetic joint infection: the economic impact of methicillin-resistant infections. J Arthroplasty 2010;25(Suppl):103-107.
22. Bozic KJ, Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg [Am] 2005;87-A:1746-1751.
23. Klekamp J, Dawson JM, Haas DW, De Boer D, Christie M. The use of vancomycin and tobramycin in acrylic bone cement: biomechanical effects and elution kinetics for use in joint arthroplasty. J Arthroplasty 1999;14:339-346.